PAMP
BIO icon

Polar Asset Management Partners’s Bio-Rad Laboratories Class A BIO Stock Holding History

Polar Asset Management Partners’s Portfolio BIO Stock Details BIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-25,000
Closed -$10.5M – 1062
2022
Q4 		$10.5M Hold
25,000
– – 0.13% 221
2022
Q3 		$10.4M Buy
+25,000
New +$12.5M 0.13% 244

Other funds holding BIO

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
VAM
Veritas Asset Management London, United Kingdom $5.56B AUM 3.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
EARNEST Partners
EARNEST Partners Atlanta, Georgia $24.3B AUM 34.41% 1-Year Est. Return

Polar Asset Management Partners's BIO Position: Q4 2023 in Review

Polar Asset Management Partners sold out of Bio-Rad Laboratories Class A (BIO) in Q4 2023, closing a stake of 19,869 shares — an estimated $7.12M sold.

Polar Asset Management Partners first reported a position in BIO in Q2 2013 and held it in 36 quarters. The position peaked at $54.4M in Q2 2019. 484 funds tracked by Wall St. Rank hold BIO as of Q4 2023.

  • Polar Asset Management Partners reported no remaining Bio-Rad Laboratories Class A position as of Q4 2023 after selling out during the quarter.
  • Polar Asset Management Partners sold 19,869 Bio-Rad Laboratories Class A shares in Q4 2023, an estimated $7.12M.
  • Polar Asset Management Partners first reported a position in Bio-Rad Laboratories Class A in Q2 2013 and held it in 36 quarters.
  • Polar Asset Management Partners's Bio-Rad Laboratories Class A position peaked at $54.4M in Q2 2019.
  • 484 funds tracked by Wall St. Rank held Bio-Rad Laboratories Class A as of Q4 2023.

Based on Polar Asset Management Partners's 13F filing for Q4 2023, filed 14 Feb 2024.